BELLUS Health is a clinical stage biotechnology company developing novel therapeutics for the treatment of chronic cough and other chronic disorders triggered by hypersensitization. The Company’s lead product candidate, BLU-5937, is a highly selective P2X3 antagonist being developed for the treatment of chronic cough and chronic pruritus. P2X3 receptors are channels expressed in sensory nerves throughout the body and play an important role in the sensitization of the nervous system to various stimuli. BELLUS is exploring how P2X3 activation contributes to irritation and pain, and whether inhibition of P2X3 receptors can help treat other afferent hypersensitization-related disorders. BELLUS Health is based in Laval, Quebec and its shares trade under the ticker BLU on both Nasdaq and the Toronto Stock Exchange.
Location: Canada, Quebec, Laval
Member count: 51-200
Total raised: $270M
Founded date: 1993
Investors 1
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 17.12.2021 | - | $200M | - | marketscre... |
| 09.09.2019 | - | $70M | - | - |
Mentions in press and media 16
| Date | Title | Description | Category | Author | Source |
| 21.12.2021 | BELLUS Hea... | Investor Presentation NASDAQ/... | - | - | marketscre... |
| 18.12.2021 | BELLUS Hea... | BELLUS Health Closes US$200 Mi... | - | - | marketscre... |
| 17.12.2021 | BELLUS Hea... | - | - | - | orbimed.co... |
| 17.12.2021 | BELLUS Hea... | BELLUS Health Inc. (NASDAQ: BL... | - | - | marketscre... |
| 15.12.2021 | BELLUS Hea... | In connection with its previou... | - | - | marketscre... |
| 14.12.2021 | BELLUS Hea... | BELLUS Health Inc. (“BELLUS He... | - | - | marketscre... |
| 01.11.2021 | Corporate ... | Investor Presentation NASDAQ/... | - | - | marketscre... |
| 12.08.2021 | UPDATED: F... | A few months ago, Merck emerge... | - | Nicole DeF... | endpts.com... |
| 24.03.2021 | BELLUS Hea... | LAVAL, Quebec--(BUSINESS WIRE)... | - | - | oaoa.com/n... |
| 22.10.2020 | BELLUS Hea... | - | - | - | orbimed.co... |
Show more